{"recordId":"st_bt761idfgjnbmsz7","canonicalUrl":"https://sotwire.com/stories/iorganbio-mitsui-chemicals-investment-organoid-manufacturing-morrisville","jsonUrl":"https://sotwire.com/stories/iorganbio-mitsui-chemicals-investment-organoid-manufacturing-morrisville/record","slug":"iorganbio-mitsui-chemicals-investment-organoid-manufacturing-morrisville","headline":"iORGANBIO lands Mitsui Chemicals investment","dek":"The Morrisville biotech and the Japanese materials maker will combine an AI-run cell lab with InnoCell culture plates to make more consistent human cells and organoids.","articleBody":"iORGANBIO, a Morrisville biotechnology company, announced on Nov. 10 that it has received an investment from Mitsui Chemicals through 321Catalyst, the Japanese chemical maker's corporate venture capital fund. The amount was not disclosed.\n\nFounded in July 2024 and led by CEO Daniel Delubac, iORGANBIO designs and manufactures human cells and organoids for drug discovery and regenerative medicine. Its platform links AI, single-cell analysis and robotics in a closed-loop autonomous lab built to produce target cells with a high degree of uniformity and reproducibility.\n\nMitsui Chemicals will contribute its materials design work, including its InnoCell cell culture plates. The companies aim to improve cell and organoid quality and to make cell types that have been hard to manufacture, and they plan to explore drug discovery tools, including efficacy and safety testing, that could complement or serve as alternatives to animal testing.\n\n\"We are thrilled to announce our growing relationship with Mitsui Chemicals,\" said Delubac. \"We are excited to partner with iORGANBIO in contributing to greater efficiency in drug discovery and advancements in cell therapy and regenerative medicine,\" said Shunsuke Fujii, PhD, GM of New Business Incubation Center, Mitsui Chemicals.","category":"funding","categoryLabel":"Funding","location":"Morrisville, NC","company":{"name":"iORGANBIO","domain":"iorgan.bio"},"sample":false,"sampleDisclaimer":null,"publishedAt":"2026-11-16T13:44:26.250Z","updatedAt":"2026-11-16T13:44:26.250Z","badge":"Desk reported","trust":{"level":"desk_reported","doctrine":"Sotwire verifies who at the company stood behind the submission. It does not independently certify every underlying company claim as true.","verifies":"which named Sotwire editor wrote this from the cited sources","doesNotCertify":"independent truth of every claim","badge":"Desk reported","verificationMethod":"Named Sotwire editor, from the cited sources. Not a company attestation, and not an independent fact-check of every sentence.","domainChecked":false},"attestation":{"attested":false},"confirmation":null,"facts":[{"label":"Investor","value":"Mitsui Chemicals, via 321Catalyst CVC fund"},{"label":"Amount","value":"Not disclosed"},{"label":"Founded","value":"July 2024"},{"label":"CEO","value":"Daniel Delubac, PhD"}],"keyEvents":[{"date":"2024-07","label":"iORGANBIO founded"},{"date":"2026-11-10","label":"Mitsui Chemicals investment announced"}],"sources":[{"url":"https://www.globenewswire.com/news-release/2026/11/10/3399347/0/en/iorganbio-and-mitsui-chemicals-collaborate-to-advance-ai-driven-human-cell-and-organoid-manufacturing.html","title":"iORGANBIO and Mitsui Chemicals Collaborate to Advance AI-Driven Human Cell and Organoid Manufacturing","publisher":"GlobeNewswire / iORGANBIO"},{"url":"https://jp.mitsuichemicals.com/en/release/2026/2026_1029/index.htm","title":"Mitsui Chemicals Invests in iOrganBio, Developer of a Human Cell Design and Manufacturing Platform","publisher":"Mitsui Chemicals"}],"source":{"url":"https://www.globenewswire.com/news-release/2026/11/10/3399347/0/en/iorganbio-and-mitsui-chemicals-collaborate-to-advance-ai-driven-human-cell-and-organoid-manufacturing.html","publisher":"iORGANBIO","publishedAt":"2026-11-10T12:09:00.000Z"},"cover":{"url":"https://sotwire.com/covers/iorganbio-mitsui-chemicals-investment-organoid-manufacturing-morrisville.webp","alt":"iORGANBIO lands Mitsui Chemicals investment","provenance":"unknown","provenanceLabel":"Unknown origin","credit":null},"images":[],"provenanceMethod":"EXIF, XMP, and filename heuristic. Not C2PA cryptographic proof, and not a judgment that the depicted event is true.","provenanceDisclaimer":"v1 labels are heuristic (EXIF, XMP, filename), not cryptographic C2PA proof. Treat them as disclosure of observed metadata, not a guarantee that the image is genuine or that the depicted event is true.","citation":"Sotwire Desk, iORGANBIO. \"iORGANBIO lands Mitsui Chemicals investment.\" Sotwire, November 16, 2026, https://sotwire.com/stories/iorganbio-mitsui-chemicals-investment-organoid-manufacturing-morrisville. Record ID: st_bt761idfgjnbmsz7. Desk reported.","sampleLabel":null,"correctionStatus":"No public corrections recorded","integrity":{"algorithm":"sha-256","hex":"529d0bdb960df8d51d99b6898e4f178055b43f5af0b206cab69c72fc441c4ff3","contentDigest":"sha-256=:Up0L25YN+NUdmbaJjk8XgFW0P1rwsgbKtpxy/EQcT/M=:","scope":"Canonical JSON record excluding the integrity object"}}